A Leap Forward in Oncology

Big Idea

CellmAbs,a spinoff from Lisbon NOVA University, offers an innovative immuno-oncology technology. It develops a new class of immunotherapies to treat solid tumours, particularly in the approach to pancreatic cancer, colorectal cancer, bladder cancer, stomach cancer, breast cancer and other cancers.


Nuno Prego Ramos e Paula Videira.

Portugal Ventures’ Investment Manager

Patrícia Costa